Characterization and identification of suspected counterfeit miltefosine capsules
Abstract
Recently, it was revealed that generic miltefosine
* Corresponding authors
a
Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
E-mail:
t.p.dorlo@amc.uva.nl
b Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, The Netherlands
Recently, it was revealed that generic miltefosine
T. P. C. Dorlo, T. A. Eggelte, P. J. de Vries and J. H. Beijnen, Analyst, 2012, 137, 1265 DOI: 10.1039/C2AN15641E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content